Atossa Therapeutics, Inc. - Common Stock — 분기별 재무제표 (NASDAQ:ATOS) | MetaTrader

전체 차트 열기 Full chart

뉴스

Atossa Therapeutics, Inc. (ATOS) Discusses Challenges in Breast Cancer Drug Development and Innovation in Clinical Research Transcript

France stocks lower at close of trade; CAC 40 down 0.14%

France stocks lower at close of trade; CAC 40 down 0.67%

France stocks higher at close of trade; CAC 40 up 0.92%

France stocks lower at close of trade; CAC 40 down 0.87%

France stocks higher at close of trade; CAC 40 up 1.33%

France stocks higher at close of trade; CAC 40 up 0.31%

Atossa presents preclinical data on endoxifen for muscular dystrophy

France stocks lower at close of trade; CAC 40 down 0.19%

France stocks higher at close of trade; CAC 40 up 1.79%

France stocks lower at close of trade; CAC 40 down 0.65%

Atos, 매출 14% 감소에도 마진 두 배 증가 (2025 회계연도)